🇦🇺 Australia Country × Condition
solid tumors Clinical Trials in Australia
Active clinical trials for solid tumors with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Enrollment
362 pts
Country
🇦🇺 Australia
Arcus Biosciences, Inc.
View Trial → NCT06973863 Phase 1
Recruiting
A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors
Enrollment
40 pts
Country
🇦🇺 Australia
PharmaEngine
View Trial → NCT07158918 Phase 1, Phase 2
Recruiting
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
Enrollment
65 pts
Country
🇦🇺 Australia
ABL Bio, Inc.
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in Australia?
There are currently 3 active clinical trials for solid tumors with sites in Australia, of which 3 are actively recruiting patients.
How can I join a solid tumors clinical trial in Australia?
To join a solid tumors clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in Australia?
Active solid tumors trials in Australia span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.